Oral administration of a curcumin-phospholipid delivery system for the treatment of central serous chorioretinopathy: a 12-month follow-up study
Fabio Mazzolani,1 Stefano Togni21Private Ophthalmology Practice, 2Indena SpA, Milan, ItalyBackground: The therapeutic effects of Meriva®, a curcumin-phospholipid (lecithin) delivery system (formulated as Norflo® tablets), on visual acuity and retinal thickness in patients with acute...
Guardado en:
Autores principales: | Mazzolani F, Togni S |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9a80c5a58c2041009413175bfabb13ee |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pilot study of oral administration of a curcumin-phospholipid formulation for treatment of central serous chorioretinopathy
por: Mazzolani F
Publicado: (2012) -
Oral mineralocorticoid antagonists for recalcitrant central serous chorioretinopathy
por: Chin EK, et al.
Publicado: (2015) -
Chronic central serous chorioretinopathy: long-term follow-up and vision-related quality of life
por: Breukink MB, et al.
Publicado: (2016) -
Central Serous Chorioretinopathy Following Oral Use of Adulterated Honey Mixed with Tadalafil: A Case Report
por: Asharari KS, et al.
Publicado: (2021) -
Central Serous Chorioretinopathy: Pathogenesis and Management
por: Semeraro F, et al.
Publicado: (2019)